Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Enliven Therapeutics, Inc. (ELVN)

45.27 +0.49 (+1.08%)
As of 9:35:51 AM EDT. Market Open.
Trade ELVN on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
124,413
119,658
104,554
83,529
38,791
Operating Income
-124,413
-119,658
-104,554
-83,529
-38,791
Net Non Operating Interest Income Expense
18,494
16,013
14,891
11,967
1,129
Other Income Expense
-8
-49
871
-22
--
Pretax Income
-105,927
-103,694
-88,792
-71,584
-37,662
Tax Provision
--
0
232
0
--
Net Income Common Stockholders
-105,927
-103,694
-89,024
-71,584
-37,662
Diluted NI Available to Com Stockholders
-105,927
-103,694
-89,024
-71,584
-37,662
Basic EPS
-1.65
-1.83
-1.89
-2.01
-0.92
Diluted EPS
-1.65
-1.83
-1.89
-2.01
-0.92
Basic Average Shares
63,369.69
56,664
47,073
35,546.22
41,100
Diluted Average Shares
63,369.69
56,664
47,073
35,546.22
41,100
Total Operating Income as Reported
-124,413
-119,658
-104,554
-83,529
-38,791
Total Expenses
124,413
119,658
104,554
83,529
38,791
Net Income from Continuing & Discontinued Operation
-105,927
-103,694
-89,024
-71,584
-37,662
Normalized Income
-105,927
-103,694
-89,713.67
-71,584
-37,662
Interest Income
18,494
16,013
14,891
11,967
1,129
Net Interest Income
18,494
16,013
14,891
11,967
1,129
EBIT
-124,413
-119,658
-104,554
-83,529
-38,791
EBITDA
-124,284
-119,395
-104,237
-83,232
-38,576
Reconciled Depreciation
129
263
317
297
215
Net Income from Continuing Operation Net Minority Interest
-105,927
-103,694
-89,024
-71,584
-37,662
Total Unusual Items Excluding Goodwill
0
0
873
0
--
Total Unusual Items
0
0
873
0
--
Normalized EBITDA
-124,284
-119,395
-105,110
-83,232
-38,576
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
183.33
0
0
12/31/2022 - 3/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: